Table Of Content

AFFECTIVE DISORDERS ELSEVIER f Affect orders 61 (2 3-26 ania Contents (Vol. 61) Nos. 1-2 — December I 2000 Research Reports Changes in depression and physical i dex os re ‘ ) ’ 1du:l ts: a longittuud inal pP erspective B.W.J.H. Penninx, DJ.H. Dex 1.Th.M i ekman, J.M. Guralnik (The Netherlands ing on response to lithtum maintenance treatment in 360 bipolar | and II disorder L. Tondo, G. Floris, J. Hennen (USA, Italy) imphetamine or |-amino-3-phenlypropane in humans or rats receiving the MAO inhibitor tra iw, K.F. McKenna, P.R. Paetsch, R.T. Coutts, G.B. Baker (Canada) p nan in won » with linthwm responsive bipolar disorder Robbins, M. Ald Be oefer, M. Vojtechovsky, A. Nilsson, C. Robertson (Canada, Germany self-report assessments of depress ymptoms in an el B.H. Brummet Barefoot, [.¢ ieglet ¢ ns (USA Human fibroblasts as a relevant model to signal transduction in affective disorders D.H. Manier Shelton, T.( lis Peterson, A. Eiring, F. Sulser (USA) d outpatients: a comparison of descnipti J. McKenz Brief Reports Further evidence for low serum cholesterol and suicidal behaviour M. Sarchiapone, A. Roy, G. Camardese, S$ Risio (Italy, USA term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and Londborg, W.T. Smith, V. Glaudin, J.R. Painter (USA) e correlates of community functioning in patients with bipolar disorder \. Kusznir, R.G. Cooke, | Young (Canada Is impaired outcome following a first manic episode due to mood-incongruent psychosis? S.M. Strakowski, J.R. Williams, K.W. Sax, D.E. Fleck, M.P. DelBello, M.L. Bourne (USA y-onset versus late-onset atypical depression: unipolar and bipolar Il F. Benazzi (Italy Obstetric complications in patients with depression a population-based case-control study A. Preti, L. Cardascia, T. Zen, P. Pellizzari, M. Marchetti, G. Favaretto, P. Miotto (Italy The Edinburgh Postnatal Depression Scale (EPDS) and the detection of major depressive disorder concerns about false negatives N. Guedeney, J. Fermanian, J.D. Guelfi, R-C. Kumar (Franc Preliminary Communications Diminished perception of ambient light: a of clinical depression T.R. Friberg, G. Borrero (USA \ double-blind, placebo-controlled, efficacy, safety, and pharmacokinetic study of INN 00835, a novel antidepressant peptide, in the treatment of major depression I.P. Feighner, R.H. Ehrensing. AJ. Kastin Sverdiov, G. Nicolau, A. Patel, J. Hlavka, H. Abajian, J.F. Nob! USA, Ireland) No. 2 — December II 2000 (Special Issue: Arousal in Anxiety)